Overview

A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers

Status:
Terminated

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to investigate the feasibility, tolerability and safety of surgical debulking and resection with heated intraoperative chemotherapy (HIPEC) followed by repeated intraperitoneal chemotherapy for treatment of recurrent ovarian, primary peritoneal, and fallopian tube carcinomas.

Phase:

Phase 2

Details

Lead Sponsor:

Columbia University

Treatments:

Cisplatin
Doxorubicin
Liposomal doxorubicin